Y. Benhamou

2.5k total citations
60 papers, 1.7k citations indexed

About

Y. Benhamou is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Y. Benhamou has authored 60 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hepatology, 42 papers in Epidemiology and 9 papers in Infectious Diseases. Recurrent topics in Y. Benhamou's work include Hepatitis C virus research (46 papers), Hepatitis B Virus Studies (29 papers) and Liver Disease Diagnosis and Treatment (22 papers). Y. Benhamou is often cited by papers focused on Hepatitis C virus research (46 papers), Hepatitis B Virus Studies (29 papers) and Liver Disease Diagnosis and Treatment (22 papers). Y. Benhamou collaborates with scholars based in France, United States and Germany. Y. Benhamou's co-authors include Thierry Poynard, Corinne Regimbeau, Vlad Ratziu, Marc Bourlière, Christine Katlama, Mark Sulkowski, Philippe Halfon, M. Munteanu, Vincent Thibault and Laurent Castéra and has published in prestigious journals such as The Lancet, Gastroenterology and Hepatology.

In The Last Decade

Y. Benhamou

57 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. Benhamou France 20 1.3k 1.2k 337 220 144 60 1.7k
Mark Danta Australia 20 1.2k 1.0× 1.3k 1.0× 460 1.4× 35 0.2× 93 0.6× 66 1.8k
I. Yap Singapore 18 332 0.3× 273 0.2× 100 0.3× 271 1.2× 371 2.6× 50 916
Fiorella Balli Italy 17 754 0.6× 511 0.4× 212 0.6× 230 1.0× 354 2.5× 34 1.3k
Michael DeMicco United States 12 636 0.5× 548 0.4× 150 0.4× 84 0.4× 216 1.5× 20 1.1k
Pier Luigi Calvo Italy 19 790 0.6× 892 0.7× 79 0.2× 37 0.2× 243 1.7× 72 1.3k
Wolf Peter Hofmann Germany 24 1.7k 1.3× 1.8k 1.5× 268 0.8× 6 0.0× 129 0.9× 72 2.3k
Maria Castedal Sweden 19 521 0.4× 776 0.6× 96 0.3× 149 0.7× 536 3.7× 51 1.3k
Alexandra E. Read United States 12 565 0.4× 618 0.5× 70 0.2× 23 0.1× 309 2.1× 13 857
J. Moussalli France 24 2.3k 1.8× 2.3k 1.9× 132 0.4× 6 0.0× 105 0.7× 56 2.7k
H. Porst Germany 12 590 0.5× 625 0.5× 47 0.1× 54 0.2× 130 0.9× 32 893

Countries citing papers authored by Y. Benhamou

Since Specialization
Citations

This map shows the geographic impact of Y. Benhamou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Benhamou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Benhamou more than expected).

Fields of papers citing papers by Y. Benhamou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Benhamou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Benhamou. The network helps show where Y. Benhamou may publish in the future.

Co-authorship network of co-authors of Y. Benhamou

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Benhamou. A scholar is included among the top collaborators of Y. Benhamou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Benhamou. Y. Benhamou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Girszyn, N., et al.. (2014). Rhumatisme psoriasique au cours d’un traitement par rituximab pour une polyangéïte avec granulomatose : une nouvelle réaction paradoxale ?. La Revue de Médecine Interne. 36(7). 491–494. 5 indexed citations
2.
Benhamou, Y., J. Moussalli, Vlad Ratziu, et al.. (2013). Telaprevir Activity in Treatment-Naive Patients Infected Hepatitis C Virus Genotype 4: A Randomized Trial. The Journal of Infectious Diseases. 208(6). 1000–1007. 20 indexed citations
3.
Bronowicki, J.‐P., Christophe Hézode, Leif Bengtsson, et al.. (2012). 1094 100% SVR IN IL28B CC PATIENTS TREATED WITH 12 WEEKS OF TELAPREVIR, PEGINTERFERON AND RIBAVIRIN IN THE PROVE2 TRIAL. Journal of Hepatology. 56. S430–S431. 34 indexed citations
4.
Pais, Raluca & Y. Benhamou. (2010). Traitements à long terme de l’hépatite chronique B chez le patient co-infecté par le VIH. Gastroentérologie Clinique et Biologique. 34. S136–S141. 1 indexed citations
5.
Poynard, Thierry, Yen Ngo, Patrick Marcellin, et al.. (2009). Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest–ActiTest) in patients infected by hepatitis B virus. Journal of Viral Hepatitis. 16(3). 203–213. 32 indexed citations
6.
Akhavan, Sepideh, Aurélie Schnuriger, Pascal Lebray, et al.. (2009). Natural Variability of NS3 Protease in Patients Infected with Genotype 4 Hepatitis C Virus (HCV): Implications for Antiviral Treatment Using Specifically Targeted Antiviral Therapy for HCV. The Journal of Infectious Diseases. 200(4). 524–527. 8 indexed citations
7.
Patel, Keyur, Y. Benhamou, Eric M. Yoshida, et al.. (2009). An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa‐2b combination therapy for chronic hepatitis C. Journal of Viral Hepatitis. 16(3). 178–186. 36 indexed citations
8.
Benhamou, Y., J. Moussalli, Vlad Ratziu, et al.. (2009). 10 RESULTS OF A PROOF OF CONCEPT STUDY (C210) OF TELAPREVIR MONOTHERAPY AND IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 4 HCV PATIENTS. Journal of Hepatology. 50. S6–S6. 47 indexed citations
9.
Poynard, Thierry, Yen Ngo, Françoise Imbert‐Bismut, et al.. (2008). Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update. Gastroentérologie Clinique et Biologique. 32(6). 8–21. 34 indexed citations
10.
Massard, Julien & Y. Benhamou. (2008). Traitement de l’hépatite chronique B chez les patients co-infectés par le VIH. Gastroentérologie Clinique et Biologique. 32(1). S20–S24. 12 indexed citations
11.
Bhagani, Sanjay, Y. Benhamou, Raffaele Bruno, et al.. (2008). European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV‐infected adults. HIV Medicine. 9(2). 82–88. 193 indexed citations
12.
Poynard, Thierry, Philippe Halfon, Laurent Castéra, et al.. (2007). Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation. Alimentary Pharmacology & Therapeutics. 25(6). 733–739. 81 indexed citations
13.
Poynard, Thierry, Philippe Halfon, Laurent Castéra, et al.. (2007). Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages. Clinical Chemistry. 53(9). 1615–1622. 194 indexed citations
14.
Sulkowski, Mark & Y. Benhamou. (2006). Therapeutic issues in HIV/HCV‐coinfected patients. Journal of Viral Hepatitis. 14(6). 371–386. 63 indexed citations
15.
16.
Cacoub, P. & Y. Benhamou. (2002). Place des interférons dans le traitement des infections par les virusde l'hépatite B et de l'hépatite C. La Revue de Médecine Interne. 23. 459S–474S. 3 indexed citations
17.
Poynard, Thierry, Corinne Regimbeau, & Y. Benhamou. (2001). Meta‐analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. 15(3). 355–361. 240 indexed citations
18.
Benhamou, Y., Vincent Thibault, Vincent Cálvez, et al.. (2001). Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study. The Lancet. 358(9283). 718–723. 221 indexed citations
19.
Blanshard, C, et al.. (1995). Treatment of AIDS-Associated Gastrointestinal Cytomegalovirus Infection with Foscarnet and Ganciclovir: A Randomized Comparison. The Journal of Infectious Diseases. 172(3). 622–628. 70 indexed citations
20.
Benhamou, Y., Ingibjörg Hilmarsdóttir, Isabelle Desportes, et al.. (1994). Association of lipid accumulation in small intestinal mucosa with decreased serum triglyceride and cholesterol levels in AIDS. Digestive Diseases and Sciences. 39(10). 2163–2169. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Danta Breakdown of academic impact, for papers by I. Yap Breakdown of academic impact, for papers by Fiorella Balli Breakdown of academic impact, for papers by Michael DeMicco Breakdown of academic impact, for papers by Pier Luigi Calvo Breakdown of academic impact, for papers by Wolf Peter Hofmann Breakdown of academic impact, for papers by Maria Castedal Breakdown of academic impact, for papers by Alexandra E. Read Breakdown of academic impact, for papers by J. Moussalli Breakdown of academic impact, for papers by H. Porst
Rankless by CCL
2026